BridgeMD
New treatment option for Long Covid19
Official title Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms
ClinicalTrials.gov ID: NCT06633666
What this study is testing
- What it's testing
- In this study, a 12-week pragmatic, randomized, double-blinded clinical trial will be conducted to evaluate the efficacy of acupuncture for the treatment of long Covid neuropsychiatric symptoms and provide reference for clinical non-drug treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- meet the clinical diagnosis of Long COVID by the World Health Organization (WHO), with no neuropsychiatric symptoms 1 year before infection with...
- aged 12 to 80 years;
- willing and able to consent, and complete all assessment and study procedures
You likely can't join if
- patients with a history of chronic neuropsychiatric symptoms;
- cardiovascular diseases pre-existing to the Covid-19 episode such as arrhythmia, heart failure, myocardial infarction, and patients with cardiac...
- documented pre-existing history of psychiatric illness, including substance abuse;
- suicidal tendencies (attempted suicide in the 12 months before the study);
- any chronic or remote neurological disorder (i.e. stroke, head trauma, epilepsy, tumor);
- those who participated in other clinical trials within one month;
See the full eligibility criteria
- meet the clinical diagnosis of Long COVID by the World Health Organization (WHO), with no neuropsychiatric symptoms 1 year before infection with Covid-19, and continue to have at least one neuropsychiatric symptom for 2...
- aged 12 to 80 years;
- willing and able to consent, and complete all assessment and study procedures
- patients with a history of chronic neuropsychiatric symptoms;
- cardiovascular diseases pre-existing to the Covid-19 episode such as arrhythmia, heart failure, myocardial infarction, and patients with cardiac pacemakers;
- documented pre-existing history of psychiatric illness, including substance abuse;
- suicidal tendencies (attempted suicide in the 12 months before the study);
- any chronic or remote neurological disorder (i.e. stroke, head trauma, epilepsy, tumor);
- those who participated in other clinical trials within one month;
- pregnant or lactating female patients;
- have surgery within two months before the study or will have a scheduled surgery during the study;
- acute brain injury or acute encephalopathy from another etiology than Covid-19 (e.g., sepsis, liver or renal failure, alcohol or drug withdrawal, drug toxicity);
- open-heart cardiac surgery or cardiac arrest during the last 6 months;
- patients who received acupuncture treatment 1 month before the start of the study;
- patients who were unable to complete the assessment during screening due to severe mental, cognitive, or emotional impairment
The study team makes the final eligibility decision.
Where it's taking place
- Kowloon Tong, Kowloon, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kowloon Tong, Kowloon, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.